Clinical trial
Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received…
NCT00058071 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00058071 |
|---|---|
| Title | Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer |
| Official title | A Randomized Phase III Trial of Amifostine vs. No Treatment for Platinum Induced Peripheral Neuropathy |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gestational Trophoblastic Tumor, Neurotoxicity, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | amifostine trihydrate |
| Enrollment | 100 |
| Start date | Mar 1, 2003 |
| Primary completion | Dec 1, 2007 |
| First posted | Apr 9, 2003 |
| Last update posted | Jul 9, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: